Expert Review of Gastroenterology & Hepatology

Papers
(The TQCC of Expert Review of Gastroenterology & Hepatology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Managing pain in irritable bowel syndrome: current perspectives and best practice75
Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis37
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions36
Small bowel transplant – novel indications and recent progress36
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors31
A narrative review on the diagnosis and management of constipation in infants27
COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?27
Gender-related differences in celiac disease presentation and follow-up in adult patients25
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?25
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)23
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management23
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences23
Recent advances in treating constipation in children23
Targeting liver metabolism: a pathway to cure hepatitis B virus?22
Irritable bowel syndrome – controversies in diagnosis and management21
The assessment of impaired liver function and prognosis in hepatocellular carcinoma21
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis21
Therapeutic drug monitoring in inflammatory bowel disease: recent developments21
Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms20
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?19
Elucidating the role of extracellular vesicles in liver injury induced by HIV19
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction18
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract17
Biliary diversion in progressive familial intrahepatic cholestasis: a systematic review and meta-analysis17
Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities17
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis17
Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma17
Investigating the correlation between COVID-19 and the progression of chronic liver disease17
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice16
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont16
The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review16
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice15
Managing bile acid diarrhea: aspects of contention15
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment15
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis15
Small bowel imaging in inflammatory bowel disease: updates for 202315
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States14
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis14
IBD in women of reproductive age: where do novel therapies fit in?14
Research progress in the role of gut microbiota and its metabolites in intrahepatic cholestasis of pregnancy14
Chronic nausea and vomiting: a diagnostic approach13
Psychological distress in inflammatory bowel disease13
Evaluating the role of endoscopic ultrasound in pancreatitis13
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective13
High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis12
The role and function of CD4+ T cells in hepatic ischemia-reperfusion injury12
Artificial intelligence implementation in pancreaticobiliary endoscopy12
Managing pediatric Crohn’s disease: recent insights12
Highlights of the drug-induced liver injury literature for 202112
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery12
Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer – a systematic review and meta-analysis12
Two-dimensional shear wave elastography for sparing endoscopy screening in patients with HBV-related compensated advanced chronic liver disease12
Diagnosing eosinophilic esophagitis in pediatric patients11
Carcinoid syndrome mimicking irritable bowel syndrome: don’t fall into the trap11
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma11
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays11
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review10
Gastroesophageal reflux disease in preterm infants: unmet needs10
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis10
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases10
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults10
Managing complications of chronic pancreatitis: a guide for the gastroenterologist10
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece9
Paraneoplastic syndromes in hepatocellular carcinoma: a review9
Reply to letter to the Editor: Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis9
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study9
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview9
Management of disease-related abdominal abscesses in Crohn’s disease9
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art9
Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment9
The TL1A inhibitors in IBD: what’s in the pot?8
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights8
PSC patient with jaundice – should we ERCP?8
Highlighting novel targets in immunotherapy for liver cancer8
Clinical management of inflammatory bowel disease from preconception to postpartum8
Acute severe ulcerative colitis: defining the precise moment for colectomy8
Characterizing Crohn’s disease phenotypes through pan-enteric capsule endoscopy8
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation8
EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?8
Systematic mapping of worldwide research on intra-pancreatic fat deposition8
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study8
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis8
Towards a better diagnosis of gastro esophageal reflux disease8
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis7
Nutritional aspects of inflammatory bowel disease7
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect7
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis7
Induction and maintenance of healing in erosive esophagitis in the United States7
Prioritization in inflammatory bowel disease therapy7
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis7
Addition of thermal ablation to systemic chemotherapy for the treatment of unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis7
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity7
2023 update on the clinical management of gastroparesis7
Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease7
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn’s disease7
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease7
The association between deprivation and the incidence and survival of patients with hepatocellular carcinoma in the West of Scotland7
Radiation safety and dose management in fluoroscopy-guided gastrointestinal procedures: current evidence and future perspectives7
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma7
Grayscale ultrasonography findings for characterization of gallbladder wall thickening in non-acute setting: a systematic review and meta-analysis7
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review6
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review6
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors6
To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease6
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease6
Recent advances in the treatment of gastrointestinal motility disorders in children6
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities6
Noninvasive electrical neuromodulation for gastrointestinal motility disorders6
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan6
Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review6
Histamine-producing bacteria and their role in gastrointestinal disorders6
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure6
Significance of nucleologenesis, ribogenesis, and nucleolar proteome in the pathogenesis and recurrence of hepatocellular carcinoma6
The eternal dichotomy between early biologic therapy and early surgery in Crohn’s disease: which should truly take precedence?6
Medical management of acute severe ulcerative colitis in the hospitalized patient6
Innovations in the diagnosis, treatment, and management of disorders of gut-brain interaction (DGBI)6
Proton beam therapy in the management of hepatocellular carcinoma6
A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis6
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms6
Adenoma detection rate in colonoscopy: how can it be improved?6
Stratification of obesity phenotypes to optimize future therapy (SOPHIA)6
0.16307997703552